secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syneos Health, Inc. (—)
CIK:        0001610950
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001193125-23-249567
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syneos Health appoints Colin Shannon as CEO; Keefe remains on exec team and board
--------------------------------------------------------------------------------

- Colin Shannon appointed CEO effective October 3, 2023, succeeding Michelle Keefe.
- Keefe remains a key member of the Executive Leadership Team and on the Board.
- Shannon previously served as Chairman and CEO of PRA Health Sciences, leading its IPO and sale to ICON.
- Keefe served as CEO for 18 months, leading the Company through its going private transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610950/000119312523249567/0001193125-23-249567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610950/000119312523249567/d462278d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-249567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer